REQUEST A DEMO
Total
USD $0.00
Search more companies

Promopharm S.A. (بروموفارم) (Morocco)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Promopharm S.A. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Societe De Promotion Pharmaceutique Du Maghreb, or Promopharm, is a Moroccan pharmaceutical company, set up in Settat in 1947. It is engaged in the production, marketing, import and export of human medicines, dermapharmaceuticals and cosmetics, as well as to the related activities in industrial production, real estate, financial and commercial sectors. The company also manufactures generic products of known brands, focusing on chronic diseases. Promopharm has established partnership with major international medicine producers and is an exclusive importer of their licensed products for Morocco. The dermopharmaceuticals and products for the cosmetic industry are delivered to both national and international laboratories, especially in Algiers and some other countries of the Sun-Saharan Africa. The company was known as Lafrabiol Co. until 1985.

Headquarters
Rue 7. Zone Industrielle Du Sahel
Soualem; Casablanca-Settat; Postal Code: 26400

Contact Details: Purchase the Promopharm S.A. (بروموفارم) report to view the information.

Website: http://www.promopharm.co.ma

Basic Information
Total Employees:
Purchase the Promopharm S.A. (بروموفارم) report to view the information.
Outstanding Shares:
Purchase the Promopharm S.A. (بروموفارم) report to view the information.
Registered Capital:
Purchase the Promopharm S.A. (بروموفارم) report to view the information.
Financial Auditors:
Purchase the Promopharm S.A. (بروموفارم) report to view the information.
Incorporation Date:
December 09, 2025
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
94.12%
Purchase this report to view the information.
5.88%
Subsidiaries
Algerie Industrie Mediterraneenne du Medicament [AIMM] (Algeria)
87.7%
Company Performance
Financial values in the chart are available after Promopharm S.A. (بروموفارم) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MAD. Absolute financial data is included in the purchased report.
Net sales revenue
6.98%
Total operating revenue
6.67%
Operating profit (EBIT)
1.71%
EBITDA
4.47%
Net Profit (Loss) for the Period
8.4%
Total assets
15.74%
Total equity
11.44%
Operating Profit Margin (ROS)
-0.48%
Net Profit Margin
0.08%
Return on Equity (ROE)
-0.13%
Debt to Equity Ratio
-4.31%
Quick Ratio
-0.22%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?